| Literature DB >> 31226138 |
Claire Godard-Sebillotte1, Mélanie Le Berre1,2,3, Tibor Schuster1, Miguel Trottier1, Isabelle Vedel1,2.
Abstract
BACKGROUND: Persons with dementia have twice the acute hospital use as older persons without dementia. In addition to straining overburdened healthcare systems, acute hospital use impacts patient and caregiver quality of life and is associated with increased risk of adverse outcomes including death. Reducing avoidable acute hospital use in persons with dementia is thus a global healthcare priority. However, evidence regarding the impact of health service interventions as defined by the Effective Practice and Organization of Care Cochrane Group on acute hospital use is scant and inconclusive. The aim of this systematic review and meta-analysis was to synthesize available evidence on the impact of health service interventions on acute hospital use in community-dwelling persons with dementia compared to usual care.Entities:
Mesh:
Year: 2019 PMID: 31226138 PMCID: PMC6588225 DOI: 10.1371/journal.pone.0218426
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Preferred reporting items for systematic reviews and meta-analysis (PRISMA) flow diagram of study selection.
Fig 1 legend: RCT, Randomised controlled trial.
Studies characteristics.
| Authors | Country | Intervention type EPOC taxonomy | Intervention duration | Type of neurocognitive disorder and severity (MMSE if available) | Sample size | Age, Mean (SD) | Female |
|---|---|---|---|---|---|---|---|
| United States | maximum of 12 months | AD; “moderate severity” (mean MMSE: 18) | I: 84; | I: 77 (6); | I: 39 (46); C: 27 (39) | ||
| United States | 12 months | Dementia diagnosis or a symptom code indicating memory loss; severity not reported | I:72; | Not reported | Not reported | ||
| United Kingdom | 6 months | MMSE lower than 24 (I: 67%; C: 54%); severity not reported | I: 129; C: 127 | I: 82 (7); | I: 96 (74); C: 92 (72) | ||
| Hong Kong | 6 months | AD (DSM IV criteria); 80% of the sample at “early (ambulatory) stage" | I: 44; | Total sample: 68 (7) | Total sample: | ||
| Hong Kong | 24 months | AD (DSM IV criteria); “mild or moderate” severity (mean MMSE: I:18, C:17) | I: 46; | I: 68 (7); | I: 19 (41); C: 21 (46) | ||
| United States | 18 months | AD, vascular dementia and other types of dementia; (Blessed-Roth Dementia Scale mean scores: I: 5, C: 6) | I: 238; C: 170 | I: 79 (6); | I: 94 (55); C: 71 (56) | ||
| Finland | 24 months | AD, vascular dementia and other types of dementia; “mild”, “moderate” and “severe” dementia (mean MMSE: 14) | I: 63; | I: 78 (7); C: 77 (6) | I: (43) | ||
| Joling 2013 | Netherlands | 12 months | Dementia diagnosis; (mean MMSE: I: 21, C: 22) | I: 96; | I: 73 (9); | I: 30 (31); C: 32 (33) | |
| Laakkonen 2016 | Finland | 8 weeks | Dementia diagnosis; “possible”, “mild”, “moderate” and “severe” dementia (mean MMSE: I: 20, C: 22) | I: 67; | I: 77 (6); | I: 25 (37); C: 26 (38) | |
| Meeuwsen 2013 | Netherlands | 12 months | AD, vascular dementia, other types of dementia; “very mild” and “mild” dementia (mean MMSE: 23) | I: 87; | I: 78 (6); | I: 54 (62); | |
| Menn 2012 | Germany | 24 months | Dementia diagnosis;”mild” and “moderate” dementia (mean MMSE: I-groupB: 19, I-groupC: 19, C: 18) | I-groupB: 109 | I-groupB: 79 (6); I-groupC: 81 (6); C: 81 (7) | I-groupB: (68) | |
| Nichols 2017 | United States | 6 months | AD, Dementia diagnosis or MMSE lower than 24; severity not reported | I: 98; | I: 80 (8); | I: 59 (60); C: 59 (60) | |
| Rubenstein, 2007 | United States | 36 months | Cognitive impairment (10-item Geriatric Postal Screening Survey); severity not reported | I: 380; C: 412 | I: 75 (6); | I: 14 (4); C: 11 (3) | |
| Samus 2014 | United States | 18 months | Dementia or “Cognitive Disorder Not Otherwise Specified” (DSM IV criteria); “mild”, “moderate” and “severe” dementia (mean MMSE: 19) | I: 110; C: 193 | I: 84 (6); | I: 73 (66); C:120 (62) | |
| Søgaard 2014 | Denmark | 36 months | AD, mixed dementia, or Lewy body dementia; “mild” dementia (mean MMSE: 24) | I: 163; C: 167 | I: 76 (8); C: 75 (7) | I: 87 (53); C: 92 (55) | |
| Thyrian 2017 | Germany | 12 months | Positive screening for dementia (DemTect procedure); “no hint for”, “mild”, “moderate” and “severe” dementia (mean MMSE: 23) | I: 408; C: 226 | I: 81 (6); | I: 178 (61); | |
| Wray 2010 | United States | 10 weeks | Diagnosis of dementia; "moderate-to-severe" dementia | I: 83; | I: 78 (7); | Not reported |
Abbreviations: AD, Alzheimer’s Disease; DSM IV, Diagnostic and Statistical Manual of Mental Disorders IV; EPOC, Effective Practice and Organization of Care Cochrane Group; MMSE, Mini-Mental State Examination; I, Intervention Group; C, Control Group
a The numbers are the randomised numbers of participants in each group (as reported or calculated).
b Denominators are the number of participants with available baseline characteristics. They differ from the randomised numbers of participants for two trials: Thyrian 2017 and Duru 2009. In Thyrian 2017, the numbers of participants with available baseline characteristics are 291 in intervention and 116 in control groups. In Duru 2009, the numbers of participants with available baseline characteristics are 170 in intervention and 126 in control groups.
c Only percentages of female participants were reported.
Intervention types and outcomes included in the meta-analysis for each study.
| Authors | Intervention type EPOC taxonomy | Outcomes | ||||
|---|---|---|---|---|---|---|
| Proportion of patients with at least one ED visit | Mean number of ED visits | Proportion of patients with at least one hospital admission | Mean number of hospital admissions | Mean number of hospital days | ||
| Callahan | ✓ | ✓ | ||||
| Bass 2003 [ | ✓ | ✓ | ||||
| Challis 2004 [ | ✓ | ✓ | ✓ | ✓ | ||
| Chien 2008 [ | ✓ | ✓ | ✓ | ✓ | ||
| Chien 2011 [ | ✓ | ✓ | ✓ | ✓ | ||
| Duru 2009 [ | ✓ | ✓ | ✓ | ✓ | ||
| Eloniemi-Sulkava 2009 [ | ✓ | ✓ | ||||
| Joling 2013 [ | ✓ | ✓ | ||||
| Laakkonen 2016 [ | ✓ | ✓ | ||||
| Menn 2012 | ✓ | ✓ | ✓ | |||
| Nichols 2017 [ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Rubenstein, 2007 [ | ✓ | ✓ | ||||
| Samus 2014 [ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Søgaard 2014 [ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Thyrian 2017 [ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Wray 2010 [ | ✓ | ✓ | ||||
Abbreviations: EPOC, Effective Practice and Organization of Care Cochrane Group.
Fig 2Pooled risk differences (2A) and pooled risk ratios (2B) for dichotomous outcomes (solid dots), 95% confidence intervals (black coloured error bars), and 95% prediction intervals (grey shaded bar plots). Fig 2 legend: ED, Emergency Department.
Fig 3Pooled mean differences for continuous outcomes (solid dots), 95% confidence intervals (black coloured error bars), and 95% prediction intervals (grey shaded bar plots).
Fig 3 legend: ED, Emergency Department.